MAPT and Alzheimer disease: Evidence suggests that Aβ and Tau oligomers contribute to dendritic spine and synaptic loss in AD, especially in the hippocampus [5], with subsequent disturbance of the glutamatergic neurotransmission machinery [6,7,8,9].